Impact of prescription size on statin adherence and cholesterol levels

BACKGROUND: Therapy with 3-Hydroxy-3-methylglutaryl Co-enzyme A reductase inhibitors (statins) improve outcomes in a broad spectrum of patients with hyperlipidemia. However, effective therapy requires ongoing medication adherence; restrictive pharmacy policies may represent a barrier to successful a...

Descripción completa

Detalles Bibliográficos
Autores principales: Batal, Holly A, Krantz, Mori J, Dale, Rita A, Mehler, Phillip S, Steiner, John F
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2174936/
https://www.ncbi.nlm.nih.gov/pubmed/17961256
http://dx.doi.org/10.1186/1472-6963-7-175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2174936/
https://www.ncbi.nlm.nih.gov/pubmed/17961256
http://dx.doi.org/10.1186/1472-6963-7-175

Ejemplares similares